Drug Search Results
Using advanced filters...
Advanced Search [+]

Butedronic acid

Alternative Names: butedronic acid
Clinical Status: Inactive
Latest Update: 2025-01-15
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: Imaging Agent,Radioactive Agent

Novel Mechanism: No

Modality: Diagnostic Agent

Route of Administration: N/A

FDA Designation: *

Approval Status: Not Approved

Approved Countries: Austria | Czech | Denmark | Finland | France | Germany | Greece | Netherlands | Norway | Slovenia | Sweden | Switzerland

Approved Indications: None

Known Adverse Events: None

Company: Medical University of Vienna
Company Location:
Company CEO:
Additional Commercial Interests: None

Clinical Description

Countries in Clinic:

Active Clinical Trial Count:

Recent & Upcoming Milestones

Highest Development Phases

Phase 2: Prostate Cancer

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Latest Trial Update Date

Data Updated

2024-519348-34-00

P2

Not yet recruiting

Prostate Cancer

2025-10-01

2025-05-02

Treatments